Investigators reported that immune checkpoint VISTA protects mouse kidneys from ischemia-reperfusion injury and progressive fibrosis. The proposed biological effects include reprogramming macrophage polarization and restraining inflammatory T-cell responses. The findings place VISTA alongside other immunoregulatory targets being tested for organ-protective effects beyond classical oncology-only development, with fibrosis as a central translational endpoint.